back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-02-27 15:21 Tx date 2023-02-13 |
$DMED
Diagnamed Holdings Corp. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-27 15:21 Tx date 2023-02-13 |
$DMED
Diagnamed Holdings Corp. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2020-12-11 22:14 Tx date 2020-10-01 |
$PHRM
Newscope Capital Corporation |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2020-12-11 22:13 Tx date 2020-10-01 |
$PHRM
Newscope Capital Corporation |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2019-06-19 14:35 Tx date 2018-06-18 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-125,000 vol |
0 | |
| Filed 2017-04-12 Tx date 2017-04-10 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
315,375 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
| Filed 2016-06-20 Tx date 2013-05-24 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-250,000 vol |
991,666 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
|
Rights
58 - Expiration of rights
|
-460,000 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-991,666 vol |
0 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
1,491,666 | |
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
|
Rights
56 - Grant of rights
|
+460,000 vol |
460,000 | |
| Filed 2016-05-24 Tx date 2013-05-24 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-24 Tx date 2016-05-20 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,241,666 vol |
1,241,666 | |
| Filed 2016-05-24 Tx date 2013-05-24 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-29 Tx date 2015-09-21 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+14,000 vol $0.45 each |
1,241,666 | |
| Filed 2015-09-29 Tx date 2015-09-21 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$740.00
+2,000 vol $0.37 each |
1,223,666 | |
| Filed 2015-09-29 Tx date 2015-09-21 |
$RVV
Revive Therapeutics Ltd. |
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,680
+4,000 vol $0.42 each |
1,227,666 |